Trending The Red Line: Aegerion Pharmaceuticals, Inc. (AEGR), Banco Santander Brasil SA (ADR) (BSBR), Allied Nevada Gold Corp. (ANV)

There is no adequate room for optimism in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), according to the analysts at Jefferies. The analysts downgraded the stock to a “Hold” from a “Buy”. They also lowered their target price on the stock to $61 from $24.

According to Jefferies, the outlook for Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was dampened by its downbeat revenue revisions for 2014.

Nonetheless, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) posted narrow losses and improved sales in 3Q. The biopharmaceutical company suffered a net loss of $5.9 million, which translated to earnings of $0.20 per share. That was better than the loss of $12.5 million or $0.43 a share in the like quarter last year. The company earned adjusted net income of $0.12 per share, which was better than the estimated loss of $0.14 per share for the quarter.

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) generated revenue of $43.67 million, below the estimate of $48.64 million but strongly above $16.33 million last year.

What does the Relative Strength Indicator (RSI) say about future trends with AEGR?

Banco Santander Brasil SA (ADR) (NYSE:BSBR) is returning to its parent Banco Santander, S.A. (ADR) (NYSE:SAN). According to the latest update, a number of investors accepted the buyout offer and relinquished 13.65% of ownership in the Brazilian bank to the parent  Banco Santander, S.A. (ADR) (NYSE:SAN). That increased the ownership of the parent to 88.3%.

Banco Santander, S.A. (ADR) (NYSE:SAN) sought to buy a minority stake in Banco Santander Brasil SA (ADR) (NYSE:BSBR) that it did not already own.

Banco Santander Brasil SA (ADR) (NYSE:BSBR) is the biggest profit earner for its Spanish parent.

Have an analyst breakdown the Bollinger Bands for BSBR.

The declining gold prices continued to push Allied Nevada Gold Corp. (NYSEMKT:ANV) deep in the red even in today’s session. The ticker saw its shares falling to a new 52-week of $1.33 on massive volume. The reports about the U.S. economy expanding at faster pace than expected also didn’t go down well with Allied Nevada Gold Corp. (NYSEMKT:ANV).

Analyst help identify trailing stop-losses for both long and short position in ANV.

About the Author

Cooper is a graduated from Buffalo State College in New York with a bachelor's degree in Broadcast Journalism.

Leave A Response